Effects of benidipine, a long-lasting dihydropyridine-Ca2+ channel blocker, on cerebral blood flow autoregulation in spontaneously hypertensive rats

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 11, 2006, Pages 2222-2225

  Ikeda, Jun Ichi ^a   Yao, Kozo ^a   Matsubara, Masahiro ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Autoregulation; Benidipine; Cerebral blood flow

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIHYDROPYRIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; BLEEDING; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN VASCULAR RESISTANCE; CARDIOVASCULAR AUTOREGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ESSENTIAL HYPERTENSION; HYPOTENSION; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

ADMINISTRATION, ORAL; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD FLOW VELOCITY; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARBON DIOXIDE; CEREBRAL CORTEX; DIHYDROPYRIDINES; HYPERTENSION; MALE; OXYGEN; RATS; RATS, INBRED SHR; RATS, WISTAR; SPECIES SPECIFICITY; TETRAZOLES; ULTRASONOGRAPHY, DOPPLER, PULSED; VASCULAR RESISTANCE;

EID: 33750606809     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.2222     Document Type: Article

References (38)

1. Strandgaard S., Paulson O. B., Stroke, 15, 413-416 (1984).
2. Paulson O. B., Waldemar G., Schmidt J. F., Strandgaard S., Am. J. Cardiol., 63, 2C-5C (1998).
3. Choi J. Y., Morris J. C., Hsu C. Y., Neurol. Clin., 16, 687-711 (1998).
4. Tietjen C. S., Hurn P. D., Ulatowski J. A., Kirsch J. R., Crit. Care Med., 24, 311-322 (1996).
5. Kitakaze M., Karasawa A., Kobayashi H., Tanaka H., Kuzuya T., Mori M., Cadiovasc. Drug Rev., 17, 1-15 (1999).
6. Kitakaze M., Node K., Minamino T., Asanuma H., Kuzuya T., Hori M., J. Am. Coll. Cardiol., 33, 242-249 (1999).
7. Kobayashi N., Kobayashi K., Hara K., Higashi T., Yanaka H., Yagi S., Matsuoka H., Am. J. Hypertens., 12, 483-491 (1999).
8. Yamashita T., Kawashima S., Ozaki M., Rikitake Y., Hirase T., Inoue N., Hirata K., Yokoyama M., J. Hypertens., 19, 451-458 (2001).
9. Matsubara M., Yao K., Hasegawa K., Pharmacol. Res., 53, 35-43 (2006).
10. Yao K., Ina Y., Nagashima K., Ohmori K., Ohno T., Biol. Pharm. Bull., 23, 766-769 (2000).
11. Yao K., Ina Y., Sonoda R., Nagashima K., Ohmori K., Ohno T., J. Pharm. Pharmacol., 55, 109-114 (2003).
12. Takase H., Sugiyama M., Nakazawa A., Sato K., Ueda R., Dohi Y., Arzneim.-Forsch., 50, 530-534 (2000).
13. Suzuki O., Yoshida T., Tani S., Kato K., Yoneyama A., Hibino T., Yokoi K., Matsubara T., Arzneim.-Forsch., 54, 505-512 (2004).
14. Paulson O. B., Waldemar G., Blood Vessels, 28, 231-235 (1991).
15. Vraamark T., Waldemar G., Strandgaard S., Paulson O. B., J. Hypertens., 13, 755-761 (1995).
16. Nishimura Y., Ito T., Saavedra J. M., Stroke, 31, 2478-2486 (2000).
17. Harris R. J., Branston N. M., Symon L., Bayhan M., Watson A., Stroke, 13, 759-766 (1982).
18. Hollerhage H. G., Gaab M. R., Zumkeller M., Walter G. F., J. Neurosurg., 69, 919-922 (1988).
19. Aihara K., Naunyn. Schmiedebergs. Arch. Pharmacol., 339, 469-473 (1989).
20. Mason R. P., Marche P., Hintze T. H., Arterioscler. Thromb. Vasc. Biol., 23, 2155-2163 (2003).
21. Cai H., Yao H., Ibayashi S., Takaba H., Fujishima M., Eur. J. Pharmacol., 313, 103-106 (1996).
22. Shirakura S., Karasawa A., Kubo K., Biol. Pharm. Bull., 16, 475-479 (1993).
23. Ueno H., Hara T., Ishi A., Shuto K., Jpn. J. Pharmacol., 84, 56-62 (2000).
24. Paxions G., Watson C., "The Rat Brain in Stereotaxic Coordinates," 2nd ed., Academic Press, San Diego, 1986.
25. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group., JAMA, 288, 2981-2997 (2002).
26. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., Olofsson B., Trenkwalder P., Zanchetti A., J. Hypertens., 21, 875-886 (2003).
27. Julius S., Kjeldsen S. E., Weber M., Brunner H. R., Ekman S., Hansson L., Hua T., Laragh J., McInnes G. T., Mitchell L., Plat F., Schork A., Smith B., Zanchetti A., Lancet, 363, 2022-2031 (2004).
28. Baumbach G. L., Heistad D. D., Hypertension, 12, 89-95 (1988).
29. Baumbach G. L., Heistad D. D., Hypertension, 13, 968-972 (1989).
30. Kitayama J., Kitazono T., Ooboshi H., Takada J., Fujishima M., Ibayashi S., Eur. J. Pharmacol., 438, 153-158 (2002).
31. Karasawa A., Kubo K., Shuto K., Oka T., Nakamizo N., Arzneim.-Forsch., 38, 1707-1712 (1988).
32. Faraci F. M., Heistad D. D., Physiol. Rev., 78, 53-97 (1998).
33. Jones S. C., Radinsky C. R., Furlan A. J., Chyatte D., Perez-Trepichio A. D., Am. J. Physiol., 276, H1253-H1262 (1999).
34. Endres M., Laufs U., Huang Z., Nakamura T., Huang P., Moskowitz M. A., Liao J. K., Proc. Natl. Acad. Sci. U.S.A., 95, 8880-8885 (1998).
35. Amin-Hanjani S., Stagliano N. E., Yamada M., Huang P. L., Liao J. K., Moskowitz M. A., Stroke, 32, 980-986 (2001).
36. Shin H. K., Hong K. W., Clin. Exp. Pharmacol. Physiol., 31, 1-7 (2004).
37. Grossman E., Messerli F. H., Am. J. Cardiol., 80, 1453-1458 (1997).
38. Karasawa A., Nomura H., Nito M., Sonoda R., Tanaka H., Kosaka N., Yamaguchi K., Kobayashi S., Folia Pharmacol. Jpn., 113, 317-326 (1999).